Dr. Abi Khalil started his training at Weill Cornell in 2012 as a fellow, and his academic carrier in 2013 as an Assistant Professor of Genetic Medicine and of Medicine.

Since joining the medical college, his scientific productivity has increased steadily, both in terms of quantity and quality. He has received grants for five projects totaling nearly 4 million dollars and, to date, he has published over 45 original research articles, reviews, and book chapters. He has been invited to speak at the annual meetings of several international societies, such as the European Society of Cardiology and the American Heart Association.

Dr Abi Khalil is particularly interested in cardiovascular complications of diabetes. His translational research is mainly centered around the genetic and epigenetic determinants of those complications, as well as other several molecular and pathophysiological aspects of the cardio-metabolic disease.

He was the recipient of the 2017 and 2018 “Paul White Dudley international scholar award”. The award is named in honor of one of Boston’s most revered cardiologists, Dr. Paul Dudley White, who was a founding father of the American Heart Association. This award epitomizes the organization’s most prestigious tribute and is bestowed annually to a Massachusetts physician dedicated to cardiovascular or stroke care.

Dr Abi Khalil serves as the vice chair of the institutional review board (IRB) and the co-chair of the data and safety monitoring board (DSMB) at Doha's campus. He also serves as a consultant in cardiology. Since his sub-specialty is cardio-metabolics, he often gets referrals of poly-vascular cardiac patients with diabetes for primary and secondary cardiovascular prevention, resistant hypertension and dyslipidemia